COI.
search Request for Consideration arrow_forward menu
close Submit Innovation
close
Healthcare & Life Sciences verified Verified Outcome TRL 9

AI-Assisted Colonoscopy (MedTech)

domain Client: A global medical technology company handshake Provider: NVIDIA / Cosmo Pharmaceuticals schedule Deploy: 2023
85 Impact
Enterprise Ready
Evidence Score: A/10
Strength: High

Executive Summary

ANALYST: COI RESEARCH

Distribution of the first FDA-cleared AI-assisted endoscopy module to detect colorectal polyps in real-time.

rate_review Analyst Verdict

"Low Risk (Commercial). Technology is proven and regulated (FDA cleared). The business model (selling AI hardware as an add-on to existing scope towers) helps stickiness."

lock
Full Audit Report Available Includes Risk Register, Technical Specs & Compliance Data.

warning The Challenge

Adenoma detection rates (ADR) in colonoscopies vary significantly between physicians. Missed polyps can lead to interval cancers. Human fatigue is a major factor.

psychology The Solution

Partnered to distribute the GI Genius™ module. Uses NVIDIA GPUs at the edge to run computer vision algorithms that highlight potential polyps on the physician's monitor in real-time.

settings_suggest Technical & Deployment Specs

Integrations
Endoscopy Towers
Deployment Model
Edge AI
Data Classification
Video (Local inference)
Estimated TCO / ROI
Hardware unit cost
POC Summary ( to )

"N/A"

shield Risk Register & Mitigation

Risk Factor Severity Mitigation Strategy
Over-reliance on AI Medium Physician remains ultimate decision maker

trending_up Impact Trajectory

Audited value realization curve

50% reduction in missed adenomas (clinical trial data) Verified Outcome
Primary KPI14% absolute increase in adenoma detection rate
Audit CycleFDA De Novo clearance

policy Compliance & Gov

  • Standards: FDA
  • Maturity (TRL): 9
  • Evidence Score: A/10
  • Data Class: Video (Local inference)

folder_shared Verified Assets

description
Verified Case Study
PDF • Version 1
lock
verified_user
Technical Audit
PDF • Audited
lock

Related Intelligence

article
Checkout-Free Concession Technology
View Outcome →
article
Super App Platform Architecture
View Outcome →
article
VR-Based Quarterback Training
View Outcome →
Security Architecture

The "Blind Verification" Protocol

How we verified these outcomes for A global medical technology company without exposing sensitive IP or identities.

Private
lock_person

1. Raw Evidence

Audit ID: #PRIV-495
Evidence: Direct SQL Logs
Public
public

2. Verified Asset

Outcome: Verified
Ref ID: #COI-495

Strategic Action Center

Identify your current stage and take the next step.

rocket_launch
Replicate This Success
Want similar results? Request a deployment consultation.
psychology_alt
Submit Challenge
Have a different problem? Submit your problem statement.
publish
Publish Case Study
Submit your own verified evidence.
thumb_up
Verify Impact
Audit your existing solution.